Suchergebnisse - "Chen, Jian-Jian"

PubPharm (7)

1

Locoregional therapies for hepatocellular carcinoma : The current status and future perspectives

enthalten in: United European gastroenterology journal | 2024

von Chen, J. | Jin, Z. | Zhong, B. | +6

2

New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma : A Living Network Meta-analysis

enthalten in: Journal of clinical and translational hepatology | 2024

von Chen, J. | Jin, Z. | Luo, B. | +4

3

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211) : a propensity score matching study

enthalten in: European radiology | 2023

von Jin, Z. | Zhong, B. | Chen, J. | +14

4

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

enthalten in: Journal of clinical and translational hepatology | 2023

von Zhong, B. | Jin, Z. | Chen, J. | +2

5

Nicosulfuron stress on the glyoxalase system and endogenous hormone content in sweet maize seedlings

enthalten in: Environmental science and pollution research international | 2023

von Wu, Z. | Wang, J. | Lin, X. | +6

6

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

enthalten in: Signal transduction and targeted therapy | 2023

von Zhu, H. | Li, H. | Huang, M. | +62

7

Letter to the editor : Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Jin, Z. | Chen, J. | Luo, B. | +2

CommentOn: Hepatology. 2022 May;75(5):1257-1274. - PMID 34918361

1
[1]